Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
20,100
Employees20,100
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
20,100
Employees20,100

CRL Key Statistics

Market cap
8.40B
Market cap8.40B
Price-Earnings ratio
-128.81
Price-Earnings ratio-128.81
Dividend yield
Dividend yield
Average volume
1.02M
Average volume1.02M
High today
High today
Low today
Low today
Open price
$169.26
Open price$169.26
Volume
0.00
Volume0.00
52 Week high
$230.02
52 Week high$230.02
52 Week low
$91.86
52 Week low$91.86

CRL News

Simply Wall St 41m
A Look at Charles River Laboratories' Valuation Following Strategic ReproTracker Partnership with Toxys

Charles River Laboratories International (CRL) has entered a strategic collaboration with Toxys, expanding its developmental and reproductive toxicology service...

A Look at Charles River Laboratories' Valuation Following Strategic ReproTracker Partnership with Toxys
Simply Wall St 1d
Could Charles River Redefine Its Competitive Edge with New Non-Animal Toxicology Platform?

Charles River Laboratories International and Toxys recently announced a collaboration granting Charles River’s clients access to ReproTracker®, an in vitro stem...

Could Charles River Redefine Its Competitive Edge with New Non-Animal Toxicology Platform?
TipRanks 6d
Charles River, Toxys announce ReproTracker collaboration

Charles River (CRL) and Toxys announced a collaboration that offers Charles River’s clients access to ReproTracker, a human stem cell-based in vitro assay that...

Analyst ratings

50%

of 20 ratings
Buy
45%
Hold
50%
Sell
5%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.